Managing atrial fibrillation to prevent stroke

Atrial fibrillation (AF) is an important risk factor of stroke and contributes to 20% of strokes in the UK; however, with appropriate intervention, the risk can be reversed. For patients with a diagnosis of non-valvular atrial fibrillation, therapeutic anticoagulation is the treatment of choice. The National Institute for Health and Care Excellence AF guidelines recommend that every patient should receive appropriate treatment and a personalised package of care; empowering them to take ownership of their healthcare needs and make informed and educated decisions about their health. However, there are still a significant proportion of patients that are not receiving effective therapeutic treatment. This article explores the current best practice requirements for AF stroke prevention, considering clinical need for diagnosis; individualised risk assessment for appropriate treatment; progress in anticoagulation options; and delivery of a patient-centred package of care in today's practice.